GADD45G antibody (AA 96-109)
Quick Overview for GADD45G antibody (AA 96-109) (ABIN1886724)
Target
See all GADD45G AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 96-109
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 96 and 109 (O95257) of GADD45G
-
-
-
-
Application Notes
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- GADD45G (Growth Arrest and DNA-Damage-Inducible, gamma (GADD45G))
-
Alternative Name
- GADD 45 gamma
-
Background
-
This gene is a member of a group of genes whose transcript levels are increased following stressful growth arrest conditions and treatment with DNA-damaging agents.The protein encoded by this gene responds to environmental stresses by mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase.The GADD45G is highly expressed in placenta.[provided by RefSeq]
Synonyms: CR6, DDIT2, GRP17, GADD45gamma -
Molecular Weight
- 17 kDa
-
Gene ID
- 10912
-
NCBI Accession
- NP_006696, NM_006705
-
Pathways
- Cell Division Cycle
Target
-